Back
Beam Therapeutics, Inc. Stock Price Chart
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
90
BEAM
Beam Therapeutics, Inc.
Last Price:
$32.51
Seasonality Move:
-23.84%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing slight buying pressure.
Beam Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.61 | Buy |
| 20-day SMA: | 27.77 | Buy |
| 50-day SMA: | 25.43 | Buy |
| 200-day SMA: | 21.22 | Buy |
| 8-day EMA: | 29.15 | Buy |
| 20-day EMA: | 27.92 | Buy |
| 50-day EMA: | 26.31 | Buy |
| 200-day EMA: | 23.58 | Buy |
Beam Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.13 | Buy |
| Relative Strength Index (14 RSI): | 73.37 | Buy |
| Chaikin Money Flow: | 1724451 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.24 - 29.14) | Buy |
| Bollinger Bands (100): | (20.41 - 27.85) | Buy |
Beam Therapeutics, Inc. Technical Analysis
| Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Beam Therapeutics, Inc. Stock
Is Beam Therapeutics, Inc. Stock a Buy?
-
Beam Therapeutics, Inc. share price is 33.69 while BEAM 8-day simple moving average is 28.61, which is a Buy signal.
-
The stock price of BEAM is 33.69 while Beam Therapeutics, Inc. 20-day SMA is 27.77, which makes it a Buy.
-
Beam Therapeutics, Inc. 50-day simple moving average is 25.43 while BEAM share price is 33.69, making it a Buy technically.
-
BEAM stock price is 33.69 and Beam Therapeutics, Inc. 200-day simple moving average is 21.22, creating a Buy signal.
BEAM Technical Analysis vs Fundamental Analysis
Buy
90
Beam Therapeutics, Inc. (BEAM)
is a Buy
Is Beam Therapeutics, Inc. a Buy or a Sell?
-
Beam Therapeutics, Inc. stock is rated a BuyThe current Beam Therapeutics, Inc. [BEAM] share price is $33.69. The Score for BEAM is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
Beam Therapeutics, Inc. Stock Info
Market Cap:
3.4B
Price in USD:
33.69
Share Volume:
7.1M
Beam Therapeutics, Inc. 52-Week Range
52-Week High:
36.44
52-Week Low:
13.53
Buy
90
Beam Therapeutics, Inc. (BEAM)
is a Buy
Beam Therapeutics, Inc. Share Price Forecast
-
What is the Beam Therapeutics, Inc. stock price today?The Beam Therapeutics, Inc. stock price is 33.69 USD today.
-
Will BEAM stock go up or go down?Beam Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Beam Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Beam Therapeutics, Inc. is not overvalued.
Is Beam Therapeutics, Inc. Stock a Buy?
-
Beam Therapeutics, Inc. share price is 33.69 while BEAM 8-day exponential moving average is 29.15, which is a Buy signal.
-
The stock price of BEAM is 33.69 while Beam Therapeutics, Inc. 20-day EMA is 27.92, which makes it a Buy.
-
Beam Therapeutics, Inc. 50-day exponential moving average is 26.31 while BEAM share price is 33.69, making it a Buy technically.
-
BEAM stock price is 33.69 and Beam Therapeutics, Inc. 200-day simple moving average is 23.58, creating a Buy signal.
Fundamental Analysis of Beam Therapeutics, Inc.
Is Beam Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.01 per share.
Technical Analysis of Beam Therapeutics, Inc.
Should I short Beam Therapeutics, Inc. stock?
-
BEAM Moving Average Covergence Divergence (MACD) indicator is 1.13, suggesting Beam Therapeutics, Inc. is a Buy
-
Beam Therapeutics, Inc. Relative Strength Index (RSI) is 73.37, which suggest Beam Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Beam Therapeutics, Inc. is (26.24 - 29.14), which suggest Beam Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Beam Therapeutics, Inc. is (20.41 - 27.85), which suggest Beam Therapeutics, Inc. is a Buy
* Beam Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.